Shareholders Equity: The sum of preferred and common equity items.
Terns Pharmaceuticals, Inc. (TERN) had Shareholders Equity of $305.23M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-24.09M |
|
-- |
|
-- |
|
$27.38M |
|
$-27.38M |
|
$3.35M |
|
$-24.03M |
|
$-24.03M |
|
$-24.09M |
|
$-24.09M |
|
$-24.09M |
|
$-24.09M |
|
$-27.38M |
|
$-27.41M |
|
91.58M |
|
91.58M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$318.95M |
|
$0.07M |
|
$1.46M |
|
$320.42M |
|
$12.91M |
|
-- |
|
$2.27M |
|
$15.19M |
|
$305.23M |
|
$305.23M |
|
|
Shareholders Equity |
$305.23M |
87.47M |
|
| Cash Flow Statement Financials | |
$-43.32M |
|
$27.46M |
|
$0.39M |
|
$161.44M |
|
$145.97M |
|
$-15.47M |
|
$6.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-43.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.89% |
|
-7.89% |
|
-7.52% |
|
-7.89% |
|
$3.49 |
|
$-0.47 |
|
$-0.47 |
|